Published by Benjamin Chiou on 20th November 2025
(Sharecast News) - The US Food and Drug Administration has approved the expanded usage of AstraZeneca's Koselugo drug to adults with neurofibromatosis type 1 (NF1) - a rare, progressive, genetic condition that can impact every organ system.
URL: http://www.digitallook.com/dl/news/story/35509628/...